I have no doubt that Dr. T has shareholders' interest at heart and I have always appreciated what he's done for Race.
However, now more than ever, I'm interested to understand what the changes (again) might mean from a timeline perspective, even if it means we might get a bigger price at the end.
An explanation soon from the company would be helpful if it is making changes to the clinical programs/strategies.
Many here have stated they are holding until buyout, but it doesn't mean everyone has the same investment timeline. We all have to make our own decisions.
Ann: Race Board and Management Team Changes, page-153
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.05 |
Change
0.300(17.1%) |
Mkt cap ! $318.4M | |||
| Open | High | Low | Value | Volume |
| $1.87 | $2.06 | $1.86 | $917.4K | 470.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 7241 | $2.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.04 | 2320 | 1 |
View Market Depth
| Last trade - 13.24pm 18/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.06 |
Change
0.300 ( 18.5 %) |
||||
| Open | High | Low | Volume | ||
| $1.86 | $2.08 | $1.86 | 30385 | ||
| Last updated 13.51pm 18/06/2024 ? | |||||
| RAC (ASX) Chart |